EMD-16388

Single-particle
3.1 Å
EMD-16388
3D View Gallery
Deposition: 21/12/2022
Map released: 19/04/2023
Last modified: 19/04/2023
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-16388

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

CryoEM density of SARS-CoV-2 S spike (3 RBDs down)

EMD-16388

Single-particle
3.1 Å
EMD-16388
3D View Gallery
Deposition: 21/12/2022
Map released: 19/04/2023
Last modified: 19/04/2023
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 Spike trimer in closed conformation

Deposition Authors: Huiskonen JT , Rissanen I , Hannula L
Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants.
Makela AR, Ugurlu H , Hannula L , Kant R , Salminen P , Fagerlund R, Maki S , Haveri A , Strandin T , Kareinen L, Hepojoki J , Kuivanen S, Levanov L , Pasternack A , Naves RA, Ritvos O , Osterlund P , Sironen T , Vapalahti O , Kipar A , Huiskonen JT , Rissanen I , Saksela K
(2023) Nat Commun , 14 , 1637 - 1637
PUBMED: 36964125
DOI: doi:10.1038/s41467-023-37290-6
ISSN: 2041-1723
Grant Support: